Log in

NASDAQ:ONXX - Onyx Pharmaceuticals Stock Price, Forecast & News

Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Onyx Pharmaceuticals, Inc (Onyx) is a biopharmaceutical company. The Company is developing therapies that target the molecular mechanisms that cause cancer. The Company has built two franchise platforms: one in kinase inhibition and one in proteasome inhibition. In its kinase inhibitor franchise, its product, Nexavar (sorafenib) tablets is approved for unresectable liver cancer and advanced kidney cancer. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryBiotechnology
SectorN/A
Current SymbolNASDAQ:ONXX
CUSIP68339910
WebN/A
Phone+1-650-2660000

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive ONXX News and Ratings via Email

Sign-up to receive the latest news and ratings for ONXX and its competitors with MarketBeat's FREE daily newsletter.


Onyx Pharmaceuticals (NASDAQ:ONXX) Frequently Asked Questions

What is Onyx Pharmaceuticals' stock symbol?

Onyx Pharmaceuticals trades on the NASDAQ under the ticker symbol "ONXX."

Has Onyx Pharmaceuticals been receiving favorable news coverage?

News headlines about ONXX stock have trended extremely positive on Saturday, InfoTrie reports. The research group identifies positive and negative press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Onyx Pharmaceuticals earned a news impact score of 5.0 on InfoTrie's scale. They also gave headlines about the biopharmaceutical company a news buzz of 6.0 out of 10, meaning that recent press coverage is somewhat likely to have an effect on the stock's share price in the near term. View News Stories for Onyx Pharmaceuticals.

Who are some of Onyx Pharmaceuticals' key competitors?

What other stocks do shareholders of Onyx Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Onyx Pharmaceuticals investors own include Sarepta Therapeutics (SRPT), Booking (BKNG), First Solar (FSLR), Alphabet (GOOG), Netflix (NFLX), Pharmacyclics (pcyc), Stratasys (SSYS), Tesla (TSLA), Vertex Pharmaceuticals (VRTX) and Chipotle Mexican Grill (CMG).

How do I buy shares of Onyx Pharmaceuticals?

Shares of ONXX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

How can I contact Onyx Pharmaceuticals?

Onyx Pharmaceuticals' mailing address is 249 E Grand Ave, SOUTH SAN FRANCISCO, CA 94080-4804, United States. The biopharmaceutical company can be reached via phone at +1-650-2660000.


MarketBeat Community Rating for Onyx Pharmaceuticals (NASDAQ ONXX)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  311 (Vote Outperform)
Underperform Votes:  242 (Vote Underperform)
Total Votes:  553
MarketBeat's community ratings are surveys of what our community members think about Onyx Pharmaceuticals and other stocks. Vote "Outperform" if you believe ONXX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ONXX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/25/2020 by MarketBeat.com Staff

Featured Article: Cash Flow

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel